Xinlei Hao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xinlei Hao has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fuzheng Qu
Department of Cardiovascular Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, Shandong, China
1 shared publication - Haiming Jiang
Department of Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, Shandong, China
1 shared publication - Jiajia Cheng
Department of Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, Shandong, China
1 shared publication - Lihua Yang
Department of Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, Shandong, China
1 shared publication - Shuo-Ran Zhao
Department of Ultrasound Intervention, Yantai Hospital of Shandong Wendeng Orthopaedics and Traumatology, Yantai, China
1 shared publication
Latest Publications
- RetractedOpen Access
- 14 March 2022
- Published by Hindawi Limited in Journal of Healthcare Engineering
- Vol. 2022, 1-4
The Clinical Effect of High-Flow Oxygen Therapy through the Nose on Patients with Acute Left Heart Failure and Hypoxemia
Objective. To evaluate the clinical efficacy of nasal high-flow oxygen therapy in patients with acute left heart failure and hypoxemia. Methods. From July 2016 to November 2018, patients with acute left heart failure complicated with hypoxemia treated in the Department of Critical Medicine of Yantai Affiliated Hospital of Binzhou Medical University were retrospectively observed (a total of 140 cases met the inclusion criteria). They were randomly divided into two groups, with 70 cases in each group. Patients were given continuous ECG monitoring, improved blood gas analysis test, and recorded HR, RR, map, SaO2, pH, PaO2, PaCO2, and Lac, perfect examination and color Doppler echocardiography, and record NT-proBNP and EF before and 24 hours after treatment. The effective rates of the two groups before and after oxygen therapy were detected. Results. There were 67 patients with high-flow oxygen therapy group improvement, 95.7% improvement rate, and 55 patients with general oxygen therapy group improvement rate. The treatment improvement rate was 78.6%. A total of 67 patients were treated with high-flow oxygen therapy. After high-flow oxygen therapy, HR (t = 18.8, ), RR (t = 19.7, ), MAP (t = 12.1, ), PaCO2 (t = 9.53, ), Lac (t = 8.69, ), and NT-proBNP (t = 7.03, ) were significantly lower than before. SaO2 (t = −12.4, ), pH (t = −12.2, ), PaO2 (t = −17.7, ), and EF (t = −13.4, ) were significantly higher than before. A total of 55 patients were in the general oxygen therapy group. After administration of ordinary oxygen therapy, HR (t = 18.2, ), RR (t = 10.8, ), MAP (t = 13.1, ), PaCO2 (t = 15.8, ), Lac (t = 7.1, ), and NT-proBNP (t = 10, ) were significantly lower than before. SaO2 (t = −15.5, ), pH (t = −4.5, ), PaO2 (t = −20, <svg xmlns:xlink="http://www.w3.org/1999/xlink"...
- 14 March 2022
- Published by Hindawi Limited in Journal of Healthcare Engineering
- Vol. 2022, 1-4
RetractedOpen AccessThe Clinical Effect of High-Flow Oxygen Therapy through the Nose on Patients with Acute Left Heart Failure and Hypoxemia
Objective. To evaluate the clinical efficacy of nasal high-flow oxygen therapy in patients with acute left heart failure and hypoxemia. Methods. From July 2016 to November 2018, patients with acute left heart failure complicated with hypoxemia treated in the Department of Critical Medicine of Yantai Affiliated Hospital of Binzhou Medical University were retrospectively observed (a total of 140 cases met the inclusion criteria). They were randomly divided into two groups, with 70 cases in each group. Patients were given continuous ECG monitoring, improved blood gas analysis test, and recorded HR, RR, map, SaO2, pH, PaO2, PaCO2, and Lac, perfect examination and color Doppler echocardiography, and record NT-proBNP and EF before and 24 hours after treatment. The effective rates of the two groups before and after oxygen therapy were detected. Results. There were 67 patients with high-flow oxygen therapy group improvement, 95.7% improvement rate, and 55 patients with general oxygen therapy group improvement rate. The treatment improvement rate was 78.6%. A total of 67 patients were treated with high-flow oxygen therapy. After high-flow oxygen therapy, HR (t = 18.8, ), RR (t = 19.7, ), MAP (t = 12.1, ), PaCO2 (t = 9.53, ), Lac (t = 8.69, ), and NT-proBNP (t = 7.03, ) were significantly lower than before. SaO2 (t = −12.4, ), pH (t = −12.2, ), PaO2 (t = −17.7, ), and EF (t = −13.4, ) were significantly higher than before. A total of 55 patients were in the general oxygen therapy group. After administration of ordinary oxygen therapy, HR (t = 18.2, ), RR (t = 10.8, ), MAP (t = 13.1, ), PaCO2 (t = 15.8, ), Lac (t = 7.1, ), and NT-proBNP (t = 10, ) were significantly lower than before. SaO2 (t = −15.5, ), pH (t = −4.5, ), PaO2 (t = −20, <svg xmlns:xlink="http://www.w3.org/1999/xlink"...